Care Access Hoboken

Clinical research site in Hoboken, New Jersey · 1600 WILLOW AVE, HOBOKEN, NJ 07030-3412 · (201) 656-7500

As of July 2026, 1 paid clinical trial is recruiting at Care Access Hoboken in Hoboken, New Jersey. Active studies at this site cover conditions such as Overweight or Obesity, Psoriasis and Dermatitis Atopic. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Care Access Hoboken (1)

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

for Psoriasis

40 locations incl. Phoenix

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT06857942·Phase 4·Recruiting·Listed Mar 2025

Apply to this trial

More research sites in Hoboken

Care Access - Hoboken (2 trials)
Hoboken Univ Med Ctr (1 trial)

Explore more

Paid clinical trials in Hoboken, NJ · New Jersey clinical trials